Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-02 · accession 0000950170-24-052788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-02 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $43.66 | -354 | 48.4K | -0.7% | -$15.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | S | D | 354 | $43.66 | 48,431 | D | — | — | (F1) Represents shares sold to pay required tax withholdings due to the vesting of RSUs. (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |